
Publications of Eike-Christian Wamhoff
All genres
Journal Article (14)
2021
Journal Article
143 (45), pp. 18977 - 18988 (2021)
A remote secondary binding pocket promotes heteromultivalent targeting of DC-SIGN. Journal of the American Chemical Society 2020
Journal Article
59 (47), pp. 21016 - 21022 (2020)
Rational design of an DNA-scaffolded high-affinity binder for langerin. Angewandte Chemie International Edition 2019
Journal Article
20 (11), pp. 4088 - 4095 (2019)
Asymmetrically branched precision glycooligomers targeting langerin. Biomacromolecules
Journal Article
5 (5), pp. 808 - 820 (2019)
A specific, glycomimetic Langerin ligand for human Langerhans cell targeting. ACS Central Science 2018
Journal Article
140 (7), pp. 2537 - 2545 (2018)
Glycomimetic, orally bioavailable LecB inhibitors block biofilm formation of Pseudomonas aeruginosa. Journal of the American Chemical Society 2017
Journal Article
23 (64), pp. 16157 - 16161 (2017)
Increased conformational flexibility of a macrocycle‒receptor complex contributes to reduced dissociation rates. Chemistry – A European Journal
Journal Article
18 (13), pp. 1183 - 1187 (2017)
Calcium-independent activation of an allosteric network in Langerin by heparin oligosaccharides. ChemBioChem: A European Journal of Chemical Biology
Journal Article
139 (Supplement C), pp. 564 - 572 (2017)
Discovery of BAZ2A bromodomain ligands. European Journal of Medicinal Chemistry
Journal Article
27 (11), pp. 2472 - 2478 (2017)
Virtual screen to NMR (VS2NMR): discovery of fragment hits for the CBP bromodomain. Bioorganic & Medicinal Chemistry Letters 2016
Journal Article
94 (11), pp. 920 - 926 (2016)
Fragment-screening of N-acetylmannosamine kinase reveals non-carbohydrate inhibitors. Canadian Journal of Chemistry
Journal Article
6, 20488 (2016)
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports
Journal Article
11 (9), pp. 2407 - 2413 (2016)
19F NMR-guided design of glycomimetic Langerin ligands. ACS Chemical Biology 2015
Journal Article
10 (3), pp. 575 - 579 (2015)
Drug discovery summit: 11th Swiss course on medicinal chemistry. ChemMedChem 2014
Journal Article
Computational and experimental prediction of human C-type lectin receptor druggability. Frontiers in immunology, 5:323 (2014)
Meeting Abstract (3)
2018
Meeting Abstract
28 (12), 185, pp. 1075 - 1076. Annual Meeting of the Society for Glycobiology, New Orleans, LA, November 05, 2018 - November 08, 2018. Oxford University Press, Oxford (2018)
Synthetic glycan analog libraries for the development of selective, high affinity ligands of siglecs and galectins. In Glycobiology, 2015
Meeting Abstract
282 Supplement 1 Ed., P15-027, p. 245 - 245. 40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Germany, July 04, 2015 - July 09, 2015. Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies, Oxford, UK (2015)
Towards small molecule-based targeted delivery to immune cells. In FEBS Journal, 2014
Meeting Abstract
248. 248th National Meeting of the American-Chemical-Society (ACS), San Francisco, CA, August 10, 2014 - August 14, 2014. (2014)
Druggability of mammalian C-type lectin receptors. In Abstracts of Papers of the American Chemical Society, Thesis - PhD (1)
2017
Thesis - PhD
Glycomimetic langerin ligands for Langerhans cell targeting. Dissertation, 320 pp., Freie Universität Berlin, Berlin (2017)